General Session
Date & Time:
March 24, 2025
8:00 AM – 9:30 AM ET
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-25-043-L99-P
Course level:
Advanced
session objectives:
What You'll Learn
- Summarize the impact of modified fatty acids in the prevention and treatment of PN related complications such as IFALD.
- Discuss the benefit of fish oil in general health and nutrition support.
- Outline the physiology of Specialized Pro-Resolving Mediators and their clinical utility.
Presenters & Topics
Mark Puder
MD, PhD Benefit of Modified Fatty Acids
Professor of Surgery
Harvard Medical School
Attending Surgeon
Department of Surgery, Boston Children's Hospital
Boston, MA
Robert Martindale
MD, PhD, FASPEN Is it Time for Bioactive Lipids, EPA and DHA to Take Center Stage in Nutritional Pharmacology Again?
Professor of Surgery
Division of Gastrointestinal and General Surgery, Oregon Health & Science University
Medical Director
Hospital Nutrition Services, Oregon Health & Science University
Portland, OR
Jesmond Dalli
PhD Insights Into the Biology of Specialized Pro-Resolving Mediators
Professor of Molecular Pharmacology
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Lipid Mediator Unit Director
William Harvey Research Institute, Queen Mary University of London
London, England United Kingdom
Moderator: Manpreet Mundi
MD
Professor of Medicine
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic
Rochester, MN